Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1993-08-16
1996-07-23
Rizzo, Nicholas
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
540108, 540109, C07D 4300, A61K 3157
Patent
active
055389600
ABSTRACT:
The present invention relates to new 17-hydrazonomethyl- and 17-hydrazono-14.beta.-hydroxy-5.beta.-androstane derivatives active on the cardiovascular system, to a process for their preparation and to pharmaceutical compositions containing same for the treatment of cardiovascular disorders, such as heart failure and hypertension.
REFERENCES:
patent: 4460509 (1984-07-01), Mosbach et al.
patent: 5380841 (1995-01-01), McCall et al.
patent: 5444055 (1995-08-01), Cerri
Chemical abstracts vol. 121:157960 (1994).
Chemical abstracts vol. 121:57780 (1994).
Bernardi Luigi
Bianchi Giuseppe
Cerri Alberto
Ferrari Patrizia
Folpini Elena
Rizzo Nicholas
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
LandOfFree
Hydrazono-5.beta., 14.beta.-androstane derivatives active on the does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydrazono-5.beta., 14.beta.-androstane derivatives active on the, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydrazono-5.beta., 14.beta.-androstane derivatives active on the will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-713138